viernes, 29 de enero de 2016

VISTOGARD: New Drug Trials Snapshot Posted

A new DRUG TRIALS SNAPSHOT FOR VISTOGARD is now available. VISTOGARD is a drug used for the emergency treatment of adults and children who received an overdose of the cancer drugs fluorouracil or capecitabine, or for patients who developed certain severe or life-threatening side effects within four days of receiving these cancer drugs.

Drug Trials Snapshots provide information about who participated in clinical trials that supported the FDA approval of new drugs. The information provided in these Snapshots also highlights whether there were any differences in the benefits and side effects among sex, race and age groups.

See more Drug Trial Snapshots or contact us with questions at

No hay comentarios:

Publicar un comentario